Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The pill and the breast.

H P Leis, M M Black, S Sall

    The Journal of Reproductive Medicine
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Synthetic estrogens in contraceptives and menopausal therapy show no overall increase in breast lesions. However, they can accelerate existing breast cancer growth and may affect incidence differently based on parity. Caution is advised for high-risk individuals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies.

    The British journal of dermatology·1997
    Same author

    Promoting mealtime communication between adolescent mothers and their infants through videotape.

    Pediatrics·1997
    Same author

    Progress and new directions in the investigation of the specific dermatoses of pregnancy.

    The Keio journal of medicine·1997
    Same author

    Squamous cell carcinoma arising in chronic lymphoedema.

    The British journal of dermatology·1997
    Same author

    A typical case of pemphigoid gestationis with a unique pattern of intercellular immunofluorescence.

    The British journal of dermatology·1997
    Same author

    Dermatitis herpetiformis and bullous pemphigoid: a developing association confirmed by immunoelectronmicroscopy.

    The British journal of dermatology·1997
    Same journal

    Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic.

    The Journal of reproductive medicine·2022
    Same journal

    Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Isolated Recurrent Hematotrachelos After Abdominal Myomectomy A Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Live Birth from Electively Cryopreserved Oocytes: A Feasible Option for Couples Opposed to Embryo Cryopreservation A Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Prevalence and Risk Factors of Ejaculation Failure on the Day of Operation Among Chinese Males Undergoing Assisted Reproductive Technique Treatments.

    The Journal of reproductive medicine·2018
    Same journal

    Efficacy and Safety of Perioperative Use of Epinephrine for Laparoscopic Myomectomy in Infertile Women with Symptomatic Solitary Intramural Uterine Fibroids A Randomized Clinical Trial.

    The Journal of reproductive medicine·2018
    See all related articles

    Area of Science:

    • Endocrinology
    • Oncology
    • Women's Health

    Background:

    • Estrogen and progesterone are key to breast development and function.
    • Synthetic forms are used in contraceptives and menopausal hormone therapy.
    • The impact of exogenous estrogens on breast lesions requires careful consideration.

    Purpose of the Study:

    • To evaluate the relationship between exogenous estrogen use and breast lesion incidence.
    • To identify specific patient subgroups that may be at increased or decreased risk.
    • To provide guidance on estrogen use in women with breast health concerns.

    Main Methods:

    • Review of existing evidence on estrogen use and breast pathology.
    • Analysis of epidemiological data regarding parity and breast cancer risk.

    Related Experiment Videos

  • Clinical recommendations based on patient presentation and risk factors.

    • Main Results:

    • No statistically significant evidence links widespread estrogen use to increased benign, premalignant, or malignant breast lesions.
    • Estrogens can accelerate the growth of pre-existing breast cancer.
    • Potential differential effects on breast cancer incidence exist based on parity (nulliparous/late vs. early).

    Conclusions:

    • Women with suspicious breast changes or dominant lumps should avoid exogenous estrogens.
    • High-risk individuals for breast cancer require caution and careful monitoring when using estrogens.
    • Consideration of estriol and progesterone in estrogen preparations may mitigate potential risks.